MEDIPOST Co., Ltd. (078160.KQ)

KRW 12000.0

(-11.37%)

Total Assets Summary of MEDIPOST Co., Ltd.

MEDIPOST Co., Ltd.'s latest annual total assets in 2023 was 449.39 Billion KRW , up 12.97% from previous year.
MEDIPOST Co., Ltd.'s latest quarterly total assets in 2024 Q2 was 442.92 Billion KRW , up 0.15% from previous quarter.
MEDIPOST Co., Ltd. reported annual total assets of 397.79 Billion KRW in 2022, up 56.55% from previous year.
MEDIPOST Co., Ltd. reported annual total assets of 254.09 Billion KRW in 2021, up 15.57% from previous year.
MEDIPOST Co., Ltd. reported quarterly total assets of 442.25 Billion KRW for 2024 Q1, down -1.59% from previous quarter.
MEDIPOST Co., Ltd. reported quarterly total assets of 394.67 Billion KRW for 2023 Q1, down -0.78% from previous quarter.

Annual Total Assets Chart of MEDIPOST Co., Ltd. (2023 - 2016)

Historical Annual Total Assets of MEDIPOST Co., Ltd. (2023 - 2016)

Year	Total Assets	Total Assets Growth
2023	449.39 Billion KRW	12.97%
2022	397.79 Billion KRW	56.55%
2021	254.09 Billion KRW	15.57%
2020	219.85 Billion KRW	2.87%
2019	213.71 Billion KRW	21.6%
2018	175.75 Billion KRW	21.51%
2017	144.64 Billion KRW	-19.31%
2016	179.26 Billion KRW	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	442.92 Billion KRW	0.15%
2024 Q1	442.25 Billion KRW	-1.59%
2023 Q1	394.67 Billion KRW	-0.78%
2023 Q4	449.39 Billion KRW	14.91%
2023 Q3	391.09 Billion KRW	-1.23%
2023 Q2	395.95 Billion KRW	0.32%
2023 FY	449.39 Billion KRW	12.97%
2022 Q2	364.86 Billion KRW	36.45%
2022 Q1	267.4 Billion KRW	5.24%
2022 Q3	366.92 Billion KRW	0.57%
2022 Q4	397.79 Billion KRW	8.41%
2021 Q4	254.09 Billion KRW	14.01%
2021 Q3	222.86 Billion KRW	0.0%

Peer Total Assets Comparison of MEDIPOST Co., Ltd.

Name	Total Assets	Total Assets Difference
HLB Co., Ltd.	751.72 Billion KRW	40.218%
iNtRON Biotechnology, Inc.	98.61 Billion KRW	-355.706%
BINEX Co., Ltd.	257.01 Billion KRW	-74.853%
Bioneer Corporation	315.48 Billion KRW	-42.444%
Anterogen.Co.,Ltd.	149.43 Billion KRW	-200.734%
CrystalGenomics, Inc.	243.11 Billion USD	-84.847%
Helixmith Co., Ltd	227.27 Billion KRW	-97.727%
Chabiotech Co.,Ltd.	1725.57 Billion KRW	73.957%
Medy-Tox Inc.	611.62 Billion KRW	26.525%
Peptron, Inc.	52.49 Billion KRW	-756.052%
Amicogen, Inc.	467.09 Billion KRW	3.791%
Genexine, Inc.	376.58 Billion KRW	-19.333%
HLB Therapeutics Co.,Ltd.	200.79 Billion KRW	-123.807%
LegoChem Biosciences, Inc.	189.5 Billion KRW	-137.144%
ALTEOGEN Inc.	256.09 Billion KRW	-75.475%
PharmaResearch Co., Ltd.	535.28 Billion KRW	16.046%
SillaJen, Inc.	76.71 Billion KRW	-485.796%
JETEMA, Co., Ltd.	252.14 Billion KRW	-78.226%
OliX Pharmaceuticals,Inc	102.82 Billion KRW	-337.046%
Genomictree Inc.	132.84 Billion KRW	-238.286%
MedPacto, Inc.	80.47 Billion KRW	-458.429%
D&D Pharmatech	79.2 Billion KRW	-467.389%
EASY BIO,Inc.	172.04 Billion KRW	-161.212%
GI Innovation, Inc.	81.34 Billion KRW	-452.485%